MedPath

Butenafine

Generic Name
Butenafine
Brand Names
Lotrimin Ultra
Drug Type
Small Molecule
Chemical Formula
C23H27N
CAS Number
101828-21-1
Unique Ingredient Identifier
91Y494NL0X

Overview

Butenafine hydrochloride is a synthetic benzylamine antifungal agent. Butenafine's mechanism of action is believed to involve the synthesis inhibition of sterols. In particular, butenafine acts to inhibit the activity of the squalene epoxidase enzyme that is essential in the formation of sterols necessary for fungal cell membranes.

Background

Butenafine hydrochloride is a synthetic benzylamine antifungal agent. Butenafine's mechanism of action is believed to involve the synthesis inhibition of sterols. In particular, butenafine acts to inhibit the activity of the squalene epoxidase enzyme that is essential in the formation of sterols necessary for fungal cell membranes.

Indication

For the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to M. furfur, interdigital tinea pedis (athlete’s foot), tinea corporis (ringworm) and tinea cruris (jock itch) due to E. floccosum, T. mentagrophytes, T. rubrum, and T. tonsurans.

Associated Conditions

  • Pityriasis versicolor
  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2020/08/31
Phase 3
Completed
2020/08/31
Phase 3
Completed
2020/08/28
Phase 3
Completed
2020/08/28
Phase 3
Completed
2019/06/26
Phase 2
UNKNOWN
United Laboratories
2012/04/19
Phase 1
Completed
2010/05/10
Phase 1
Terminated
2009/02/03
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Butenafine Hydrochloride Liniment
国药准字H20080621
化学药品
搽剂
12/12/2023
Butenafine Hydrochloride Liniment
国药准字H20040791
化学药品
搽剂
6/1/2020
Butenafine Hydrochloride Liniment
国药准字H20031311
化学药品
搽剂
2/6/2020
Butenafine Hydrochloride Gel
国药准字H20060783
化学药品
凝胶剂
6/22/2020
Butenafine Hydrochloride spray
国药准字H20031312
化学药品
喷雾剂
2/6/2020
Butenafine Hydrochloride Cream
国药准字H20031310
化学药品
乳膏剂
2/6/2020
Butenafine Hydrochloride Cream
国药准字H20020025
化学药品
乳膏剂
9/30/2019
Butenafine Hydrochloride Cream
国药准字H20183065
化学药品
乳膏剂
3/17/2023
Butenafine Hydrochloride Cream
国药准字H20030460
化学药品
乳膏剂
2/16/2020
Butenafine Hydrochloride Cream
国药准字H20040790
化学药品
乳膏剂
6/1/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath